Cargando…

Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model(®) for Rapid Relative Effectiveness Assessment

BACKGROUND: Stool DNA testing for early detection of colorectal cancer (CRC) is a non-invasive technology with the potential to supplement established CRC screening tests. The aim of this health technology assessment was to evaluate effectiveness and safety of currently CE-marked stool DNA tests, co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stürzlinger, Heidi, Conrads-Frank, Annette, Eisenmann, Alexander, Invansits, Sarah, Jahn, Beate, Janzic, Andrej, Jelenc, Marjetka, Kostnapfel, Tatja, Mencej Bedrac, Simona, Mühlberger, Nikolai, Siebert, Uwe, Sroczynski, Gaby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326527/ https://www.ncbi.nlm.nih.gov/pubmed/37426885 http://dx.doi.org/10.3205/000320

Ejemplares similares

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
por: Mühlberger, Nikolai, et al.
Publicado: (2009)

Causal evidence in health decision making: methodological approaches of causal inference and health decision science
por: Kühne, Felicitas, et al.
Publicado: (2022)

The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany
por: Schaffner, Monika, et al.
Publicado: (2020)

An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply
por: Bicher, Martin, et al.
Publicado: (2022)

Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review
por: Sroczynski, Gaby, et al.
Publicado: (2020)

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review
por: Conrads-Frank, Annette, et al.
Publicado: (2022)

Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung: Kontrafaktischer Ansatz zur Kausalinferenz aus Real-World-Daten
por: Kuehne, Felicitas, et al.
Publicado: (2023)

Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
por: Siebert, Uwe, et al.
Publicado: (2003)

The many faces of estrogen signaling
por: Vrtačnik, Peter, et al.
Publicado: (2014)

Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical
por: Mittendorf, Thomas, et al.
Publicado: (2007)

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
por: Mühlberger, Nikolai, et al.
Publicado: (2017)

A qualitative exploration of travel-related risk behaviours of injection drug users from two Slovene regions
por: Kostnapfel, Tatja, et al.
Publicado: (2011)

Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity
por: Siebert, Uwe, et al.
Publicado: (2008)

Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria
por: Jahn, Beate, et al.
Publicado: (2019)

Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
por: Vukićević, Đurđa, et al.
Publicado: (2020)

Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants
por: Seidl, Astrid, et al.
Publicado: (2018)

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations
por: Hallsson, Lára R., et al.
Publicado: (2023)

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective
por: Kisser, Agnes, et al.
Publicado: (2021)

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany
por: Sroczynski, Gaby, et al.
Publicado: (2010)

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
por: Jahn, Beate, et al.
Publicado: (2017)

POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study
por: Jahn, B, et al.
Publicado: (2022)

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study
por: Jahn, B., et al.
Publicado: (2022)

HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?
por: Jahn, B, et al.
Publicado: (2022)

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation
por: Jahn, Beate, et al.
Publicado: (2021)

Developments in National Cancer Control Programmes in Europe – Results From the Analysis of a Pan-European Survey
por: Jelenc, Marjetka, et al.
Publicado: (2021)

Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR
por: Hoffmann, Sabine, et al.
Publicado: (2020)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Navigating HTA implementation: a review of Indonesia’s revised HTA guideline
por: Chavarina, Kinanti Khansa, et al.
Publicado: (2023)

GMS-HTA: Information out of the world of HTA - up-to-date, comprehensive and valid
por: Rüther, Alric
Publicado: (2005)

Evaluation of undetected cases during the COVID-19 epidemic in Austria
por: Rippinger, C., et al.
Publicado: (2021)

HTA Training for Healthcare Professionals: International Overview of Initiatives Provided by HTA Agencies and Organizations
por: Hoxhaj, Ilda, et al.
Publicado: (2022)

The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)

Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines
por: Lach, Krzysztof, et al.
Publicado: (2017)

HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022)

HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19
por: Warttig, S, et al.
Publicado: (2022)

HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe
por: Hutcheson, R, et al.
Publicado: (2022)

Use of Surrogate end points in HTA
por: Mangiapane, Sandra, et al.
Publicado: (2009)

Ethics in HTA: Examining the "Need for Expansion"
por: Abrishami, Payam, et al.
Publicado: (2017)

Impact of COVID-19 pandemic on HTA
Publicado: (2020)

Joint Action European Partnership for Action Against Cancer
por: Jelenc, Marjetka, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iei2udjat9idss6499rj3og090